{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:57:32Z","timestamp":1761541052057,"version":"3.44.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":5194,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ajpath.2011.02.026","type":"journal-article","created":{"date-parts":[[2011,6,23]],"date-time":"2011-06-23T14:37:38Z","timestamp":1308839858000},"page":"2938-2948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Redistribution and Hemostatic Action of Recombinant Activated Factor VII Associated with Platelets"],"prefix":"10.1016","volume":"178","author":[{"given":"Irene","family":"Lopez-Vilchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla","family":"Hedner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Altisent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maribel","family":"Diaz-Ricart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gines","family":"Escolar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Galan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2011.02.026_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1537-2995.2002.00017.x","article-title":"Potential role for rFVIIa in transfusion medicine","volume":"42","author":"Hedner","year":"2002","journal-title":"Transfusion"},{"issue":"2 Suppl 1","key":"10.1016\/j.ajpath.2011.02.026_bib2","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1053\/j.seminhematol.2008.03.013","article-title":"Further understanding of recombinant activated factor VII mode of action","volume":"45","author":"Monroe","year":"2008","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ajpath.2011.02.026_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.med.59.061606.095605","article-title":"Tissue factor and factor VIIa as therapeutic targets in disorders of hemostasis","volume":"59","author":"Hedner","year":"2008","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ajpath.2011.02.026_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/09537100802406653","article-title":"Understanding the therapeutic action of recombinant factor VIIa in platelet disorders","volume":"19","author":"Hers","year":"2008","journal-title":"Platelets"},{"key":"10.1016\/j.ajpath.2011.02.026_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0037-1963(01)90140-4","article-title":"The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis","volume":"38","author":"Hoffman","year":"2001","journal-title":"Semin Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2011.02.026_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-2006-939552","article-title":"A cell-based model of thrombin generation","volume":"32","author":"Roberts","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ajpath.2011.02.026_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0037-1963(01)90141-6","article-title":"Recombinant factor VIIa (NovoSeven\u00ae) restores deficient coagulation: experience from an ex vivo model","volume":"38","author":"Galan","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ajpath.2011.02.026_bib8","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1046\/j.1538-7836.2003.00225.x","article-title":"Mechanism of action of recombinant factor VIIa","volume":"1","author":"Lisman","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajpath.2011.02.026_bib9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1537-2995.2003.00427.x","article-title":"Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders","volume":"43","author":"Gal\u00e1n","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.ajpath.2011.02.026_bib10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/clpt.1994.80","article-title":"Pharmacokinetics and pharmacodynamics of recombinant factor VIIa","volume":"55","author":"Lindley","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2011.02.026_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0037-1615148","article-title":"Population pharmacokinetics of recombinant factor VIIa in volunteers anticoagulated with acenocoumarol","volume":"80","author":"Girard","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajpath.2011.02.026_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-2000-8457","article-title":"Pharmacokinetics of recombinant activated factor VII (rFVIIa)","volume":"26","author":"Erhardtsen","year":"2000","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2011.02.026_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000057294","article-title":"The evidence behind inhibitor treatment with recombinant factor VIIa","volume":"32","author":"Ludlam","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.ajpath.2011.02.026_bib14","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2516.2007.01455.x","article-title":"Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres","volume":"13","author":"Morfini","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.ajpath.2011.02.026_bib15","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/j.1538-7836.2007.02663.x","article-title":"Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors","volume":"5","author":"Konkle","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajpath.2011.02.026_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MBC.0b013e3282f544ff","article-title":"Prophylaxis with recombinant-activated factor VII (rFVIIa) for minimally invasive surgery in a patient with congenital factor VII deficiency: a case report with a single-low dose of rFVIIa","volume":"19","author":"Yilmaz","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ajpath.2011.02.026_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2516.2008.01915.x","article-title":"Prophylaxis in 10 patients with severe haemophilia A and inhibitor: different approaches for different clinical situations","volume":"15","author":"Jim\u00e9nez-Yuste","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.ajpath.2011.02.026_bib18","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1111\/j.1538-7836.2006.02166.x","article-title":"Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors","volume":"4","author":"Hedner","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajpath.2011.02.026_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1096\/fj.02-0574fje","article-title":"Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets","volume":"17","author":"M\u00fcller","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2011.02.026_bib20","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.107.141911","article-title":"Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis","volume":"27","author":"Mackman","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2011.02.026_bib21","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1084\/jem.20061302","article-title":"Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets","volume":"203","author":"Schwertz","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2011.02.026_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1160\/TH06-04-0216","article-title":"Tissue factor-enriched vesicles are taken up by platelets and induce platelet aggregation in the presence of factor VIIa","volume":"97","author":"Lopez-Vilchez","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajpath.2011.02.026_bib23","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1161\/01.ATV.14.12.1976","article-title":"Tissue factor-induced coagulation triggers platelet thrombus formation as efficiently as fibrillar collagen at arterial blood flow conditions","volume":"14","author":"Orvim","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.ajpath.2011.02.026_bib24","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/01.ATV.14.5.824","article-title":"Annexin v inhibits the procoagulant activity of matrices of TNF- stimulated endothelium under blood flow conditions","volume":"14","author":"Vanheerde","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.ajpath.2011.02.026_bib25","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1182\/blood-2008-02-139113","article-title":"The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface","volume":"112","author":"Weeterings","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.02.026_bib26","doi-asserted-by":"crossref","first-page":"11849","DOI":"10.1074\/jbc.M609283200","article-title":"Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium","volume":"282","author":"Ghosh","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.02.026_bib27","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1538-7836.2007.02648.x","article-title":"Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity","volume":"5","author":"L\u00f3pez-Sagaseta","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajpath.2011.02.026_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1538-7836.2009.03696.x","article-title":"Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)","volume":"8","author":"Gopalakrishnan","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajpath.2011.02.026_bib29","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.thromres.2010.04.002","article-title":"Preanalytical treatment of EDTA-anticoagulated blood to ensure stabilization of the mean platelet volume and component measured with the ADVIA counters","volume":"126","author":"Diaz-Ricart","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajpath.2011.02.026_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1097-0320(19960401)23:4<284::AID-CYTO4>3.0.CO;2-H","article-title":"Flow cytometric detection of intracellular platelet antigens","volume":"23","author":"Sedlmayr","year":"1996","journal-title":"Cytometry"},{"key":"10.1016\/j.ajpath.2011.02.026_bib31","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1182\/blood-2003-07-2597","article-title":"Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells","volume":"104","author":"Tenedini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.02.026_bib32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1046\/j.1537-2995.1999.39090951.x","article-title":"Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage","volume":"39","author":"Lozano","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.ajpath.2011.02.026_bib33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2362.2006.01698.x","article-title":"Antithrombotic action of annexin V proved as efficient as direct inhibition of tissue factor or thrombin","volume":"36","author":"Gal\u00e1n","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ajpath.2011.02.026_bib34","first-page":"219","article-title":"Digital image analysis of platelet-extracellular matrix interactions: studies in von Willebrand disease patients and aspirin-treated donors","volume":"24","author":"Diaz-Ricart","year":"1994","journal-title":"Haemostasis"},{"key":"10.1016\/j.ajpath.2011.02.026_bib35","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0168-8278(03)00454-9","article-title":"Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vivo model","volume":"39","author":"Tonda","year":"2003","journal-title":"J Hepatology"},{"key":"10.1016\/j.ajpath.2011.02.026_bib36","first-page":"8","article-title":"Development of a computer program to analyze the parameters of platelet-vessel wall interaction","volume":"16","author":"Escolar","year":"1986","journal-title":"Haemostasis"},{"key":"10.1016\/j.ajpath.2011.02.026_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-3148.2006.00645.x","article-title":"An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit","volume":"16","author":"Anderson","year":"2006","journal-title":"Transfus Med"},{"key":"10.1016\/j.ajpath.2011.02.026_bib38","first-page":"3","article-title":"Effects of small latex particle uptake on the surface connected canalicular system of blood platelets: a freeze-fracture and cytochemical study","volume":"5","author":"White","year":"1982","journal-title":"Diagn Histopathol"},{"key":"10.1016\/j.ajpath.2011.02.026_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-0038-1648392","article-title":"Transport of anti-glycoprotein IIb\/IIIa-antibodies into the alpha granules of unstimulated human blood platelets","volume":"67","author":"Morgenstern","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajpath.2011.02.026_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/09537100400007390","article-title":"Platelets are covercytes, not phagocytes: uptake of bacteria involves channels of the open canalicular system","volume":"16","author":"White","year":"2005","journal-title":"Platelets"},{"key":"10.1016\/j.ajpath.2011.02.026_bib41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high-dose factor VIIa is independent of tissue factor","volume":"99","author":"Monroe","year":"1997","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2011.02.026_bib42","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.thromres.2010.01.025","article-title":"Platelet binding and activity of recombinant factor VIIa","volume":"125","author":"Hoffman","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajpath.2011.02.026_bib43","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1182\/blood.V81.3.734.734","article-title":"Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation","volume":"81","author":"Morrissey","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.02.026_bib44","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.0041-1132.2004.00439.x","article-title":"Hemostatic effect of activated recombinant factor VIIa in Bernard-Soulier syndrome: studies in an in vitro model","volume":"44","author":"Tonda","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.ajpath.2011.02.026_bib45","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1538-7836.2003.00242.x","article-title":"The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII\/FIX","volume":"1","author":"He","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2011.02.026_bib46","first-page":"S61","article-title":"Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII","volume":"9","author":"Hoffman","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ajpath.2011.02.026_bib47","first-page":"1","article-title":"Traffic of rFVIIa through endothelial cells and redistribution into subendothelium: implications for a prolonged hemostatic effect","volume":"1","author":"Lopez-Vilchez","year":"2009","journal-title":"J Coag Disorders"},{"key":"10.1016\/j.ajpath.2011.02.026_bib48","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1538-7836.2008.02979.x","article-title":"Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor","volume":"6","author":"White","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajpath.2011.02.026_bib49","first-page":"1934","article-title":"Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice","volume":"118","author":"Ghosh","year":"2008","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2011.02.026_bib50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1538-7836.2009.03422.x","article-title":"Platelet hyperreactivity, scavenger receptors and atherothrombosis","volume":"7","author":"Valiyaveettil","year":"2009","journal-title":"J Thromb Haemost"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401100246X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401100246X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:33:39Z","timestamp":1755736419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000294401100246X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S000294401100246X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.02.026","relation":{},"ISSN":["0002-9440"],"issn-type":[{"type":"print","value":"0002-9440"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redistribution and Hemostatic Action of Recombinant Activated Factor VII Associated with Platelets","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}